Effects of erythropoietin therapy on the lipid profile in end-stage renal failure

This publication has 16 references indexed in Scilit:

• High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.
  Circulation, 1992
• Blood Lipid Profile in Hemodialysis Patients Treated with Human Erythropoietin
  Nephron, 1992
• Effect of Recombinant Human Erythropoietin on Nutritional Status and Plasma Lipids in Uremic Patients
  Nephron, 1992
• Iron stores and the international variation in mortality from coronary artery disease
  Medical Hypotheses, 1991
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Blood Lipids in Haemodialysis Patients Treated with Erythropoietin
  Nephrology Dialysis Transplantation, 1990
• Treatment of the Anemia of Progressive Renal Failure with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1989
• The Lipid Research Clinics Coronary Primary Prevention Trial Results
  JAMA, 1984
• Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis
  The American Journal of Clinical Nutrition, 1978
• Observations on the pathogenesis, complications and treatment of diabetes in 115 cases of haemochromatosis
  The American Journal of Medicine, 1972